Cargando…

Towards the De Novo Design of HIV-1 Protease Inhibitors Based on Natural Products

Acquired immunodeficiency syndrome (AIDS) caused by the human immunodeficiency virus (HIV) continues to be a public health problem. In 2020, 680,000 people died from HIV-related causes, and 1.5 million people were infected. Antiretrovirals are a way to control HIV infection but not to cure AIDS. As...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chávez-Hernández, Ana L., Juárez-Mercado, K. Eurídice, Saldívar-González, Fernanda I., Medina-Franco, José L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698858/ https://www.ncbi.nlm.nih.gov/pubmed/34944448 http://dx.doi.org/10.3390/biom11121805

Ejemplares similares

Cheminformatics to Characterize Pharmacologically Active Natural Products
por: Medina-Franco, José L., et al.
Publicado: (2020)

Inhibitors of DNA Methyltransferases From Natural Sources: A Computational Perspective
por: Saldívar-González, Fernanda I., et al.
Publicado: (2018)

Expanding the Structural Diversity of DNA Methyltransferase Inhibitors
por: Juárez-Mercado, K. Eurídice, et al.
Publicado: (2020)

Chemical Multiverse: An Expanded View of Chemical Space
por: Medina‐Franco, José L., et al.
Publicado: (2022)

Design of a multi-target focused library for antidiabetic targets using a comprehensive set of chemical transformation rules
por: Saldívar-González, Fernanda I., et al.
Publicado: (2023)

BIOFACQUIM: A Mexican Compound Database of Natural Products
por: Pilón-Jiménez, B. Angélica, et al.
Publicado: (2019)

Non-active site mutants of HIV-1 protease influence resistance and sensitisation towards protease inhibitors
por: Bastys, Tomas, et al.
Publicado: (2020)

Art driven by visual representations of chemical space
por: Gaytán-Hernández, Daniela, et al.
Publicado: (2023)

Legumes Protease Inhibitors as Biopesticides and Their Defense Mechanisms against Biotic Factors
por: Rodríguez-Sifuentes, Lucio, et al.
Publicado: (2020)

Off-Target-Based Design of Selective HIV-1 PROTEASE Inhibitors
por: Monica, Gabriele La, et al.
Publicado: (2021)

Natural product drug discovery in the artificial intelligence era
por: Saldívar-González, F. I., et al.
Publicado: (2021)

Interdependence of Inhibitor Recognition in HIV-1 Protease
por: Paulsen, Janet L., et al.
Publicado: (2017)

Protease-Mediated Maturation of HIV: Inhibitors of Protease and the Maturation Process
por: Adamson, Catherine S.
Publicado: (2012)

Current and Novel Inhibitors of HIV Protease
por: Pokorná, Jana, et al.
Publicado: (2009)

Strategies Towards Protease Inhibitors for Emerging Flaviviruses
por: Nitsche, Christoph
Publicado: (2018)

Next generation sequencing of HIV-1 protease in the PIVOT trial of protease inhibitor monotherapy
por: Dunn, David T., et al.
Publicado: (2018)

Discovery of SARS-CoV-2 main protease inhibitors using a synthesis-directed de novo design model
por: Morris, Aaron, et al.
Publicado: (2021)

Chemoinformatics-based enumeration of chemical libraries: a tutorial
por: Saldívar-González, Fernanda I., et al.
Publicado: (2020)

Exploring the chemical space and the bioactivity profile of lactams: a chemoinformatic study
por: Saldívar-González, Fernanda I., et al.
Publicado: (2019)

Fragment Library of Natural Products and Compound Databases for Drug Discovery †
por: Chávez-Hernández, Ana L., et al.
Publicado: (2020)

Towards designing of a potential new HIV-1 protease inhibitor using QSAR study in combination with Molecular docking and Molecular dynamics simulations
por: Baassi, Mouna, et al.
Publicado: (2023)

Role of Gag in HIV Resistance to Protease Inhibitors
por: Clavel, François, et al.
Publicado: (2010)

Flavonoid Derivatives as New Potent Inhibitors of Cysteine Proteases: An Important Step toward the Design of New Compounds for the Treatment of Leishmaniasis
por: Lourenço, Estela Mariana Guimarães, et al.
Publicado: (2023)

Reviewing HIV-1 Gag Mutations in Protease Inhibitors Resistance: Insights for Possible Novel Gag Inhibitor Designs
por: Su, Chinh Tran-To, et al.
Publicado: (2019)

Alteration of HIV epitope processing and presentation by HIV protease inhibitors
por: Kourjian, G, et al.
Publicado: (2012)

Towards a unified Latin American Natural Products Database: LANaPD
por: L Medina-Franco, José
Publicado: (2020)

Computational Simulation of HIV Protease Inhibitors to the Main Protease (Mpro) of SARS-CoV-2: Implications for COVID-19 Drugs Design
por: Yu, Wei, et al.
Publicado: (2021)

Design, synthesis, and evaluation of Bothrops venom serine protease peptidic inhibitors
por: da Silva, Gloria Maria, et al.
Publicado: (2021)

Computational screening of phytochemicals from three medicinal plants as inhibitors of transmembrane protease serine 2 implicated in SARS-CoV-2 infection
por: Oyedara, Omotayo O., et al.
Publicado: (2021)

Learning from Nature: From a Marine Natural Product to Synthetic Cyclooxygenase‐1 Inhibitors by Automated De Novo Design
por: Friedrich, Lukas, et al.
Publicado: (2021)

De novo designed protein inhibitors of amyloid aggregation and seeding
por: Murray, Kevin A., et al.
Publicado: (2022)

The Second-Generation Maturation Inhibitor GSK3532795 Maintains Potent Activity Toward HIV Protease Inhibitor–Resistant Clinical Isolates
por: Ray, Neelanjana, et al.
Publicado: (2017)

Outcome of protease inhibitor substitution with nevirapine in HIV-1 infected children
por: Gonzalez-Tome, M Isabel, et al.
Publicado: (2008)

HIV Protease Inhibitors: Effect on the Opportunistic Protozoan Parasites
por: Alfonso, Yenisey, et al.
Publicado: (2011)

Safety of protease inhibitors in HIV-infected pregnant women
por: Chougrani, Imène, et al.
Publicado: (2013)

Applications of Click Chemistry in the Development of HIV Protease Inhibitors
por: Mudgal, Mukesh M., et al.
Publicado: (2018)

The Anti-Cancer Properties of the HIV Protease Inhibitor Nelfinavir
por: Subeha, Mahbuba R., et al.
Publicado: (2020)

Efficient Strategy to Design Protease Inhibitors: Application to Enterovirus 71 2A Protease
por: Chen, Ting, et al.
Publicado: (2022)

Molecular mechanisms and design principles for promiscuous inhibitors to avoid drug resistance: Lessons learned from HIV‐1 protease inhibition
por: Shen, Yang, et al.
Publicado: (2015)

De novo design of novel protease inhibitor candidates in the treatment of SARS-CoV-2 using deep learning, docking, and molecular dynamic simulations
por: Arshia, Amir Hossein, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4o30kgqaj57ld6vci7socbpj3a